2-Hydroxyestradiol Overcomes Mesenchymal Stem Cells-Mediated Platinum Chemoresistance in Ovarian Cancer Cells in an ERK-Independent Fashion
Ovarian cancer (OC) is the second most common type of gynecological malignancy. Platinum (Pt)-based chemotherapy is the standard of care for OC, but toxicity and acquired chemoresistance has proven challenging. Recently, we reported that sensitivity to platinum was significantly reduced in a co-cult...
Main Authors: | Hazem Khamaisi, Hatem Mahmoud, Jamal Mahajna |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/3/804 |
Similar Items
-
Flavonoids Restore Platinum Drug Sensitivity to Ovarian Carcinoma Cells in a Phospho-ERK1/2-Dependent Fashion
by: Yifat Koren Carmi, et al.
Published: (2020-09-01) -
Ovarian cancer ascites confers platinum chemoresistance to ovarian cancer cells
by: Yifat Koren Carmi, et al.
Published: (2024-06-01) -
Secreted Soluble Factors from Tumor-Activated Mesenchymal Stromal Cells Confer Platinum Chemoresistance to Ovarian Cancer Cells
by: Yifat Koren Carmi, et al.
Published: (2023-04-01) -
Urocortin stimulates the ERK1/2 signaling pathway and the proliferation of HeLa cells via CRF receptor 1
by: Bálint Balogh, et al.
Published: (2023-05-01) -
Predicting response to platinum and non-platinum drugs through bioluminescence resonance energy transfer (BRET) based bio-molecular interactions in platinum resistant epithelial ovarian cancer
by: Aniketh Bishnu, et al.
Published: (2021-11-01)